Huei Wang - Researcher Profile | RDL Research Database

Publications

2 shown

Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial

Marc S. Sabatine , Robert P. Giugliano , Anthony Keech +7 more

2015 American Heart Journal 171 citations

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Marc S. Sabatine , Robert P. Giugliano , Anthony Keech +9 more

In our trial, inhibition of PCSK9 with evolocumab on a background of statin therapy lowered LDL cholesterol levels to a median of 30 mg per deciliter (0.78 mmol per liter) and r...

2017 New England Journal of Medicine 5552 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 5,723
Institution: Amgen (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-9903-1979

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.